Chemoinformaics analysis of 5-HYDROXY-7-METHOXY-2-METHYLCHROMEN-4-ONE
| Molecular Weight | 206.197 | nRot | 1 |
| Heavy Atom Molecular Weight | 196.117 | nRig | 14 |
| Exact Molecular Weight | 206.058 | nRing | 2 |
| Solubility: LogS | -4.375 | nHRing | 1 |
| Solubility: LogP | 3.346 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 25 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 1 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 10 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 11 |
| nHA | 4 | APOL | 28.2459 |
| nHD | 1 | BPOL | 14.3721 |
| QED | 0.462 |
| Synth | 1.929 |
| Natural Product Likeliness | 0.385 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.462 |
| Pgp-sub | 0 |
| HIA | 0.004 |
| CACO-2 | -4.517 |
| MDCK | 0.0000198 |
| BBB | 0.139 |
| PPB | 1.00302 |
| VDSS | 0.652 |
| FU | 0.0108876 |
| CYP1A2-inh | 0.99 |
| CYP1A2-sub | 0.805 |
| CYP2c19-inh | 0.972 |
| CYP2c19-sub | 0.138 |
| CYP2c9-inh | 0.918 |
| CYP2c9-sub | 0.749 |
| CYP2d6-inh | 0.342 |
| CYP2d6-sub | 0.122 |
| CYP3a4-inh | 0.396 |
| CYP3a4-sub | 0.264 |
| CL | 8.628 |
| T12 | 0.672 |
| hERG | 0.1 |
| Ames | 0.054 |
| ROA | 0.032 |
| SkinSen | 0.913 |
| Carcinogencity | 0.434 |
| EI | 0.979 |
| Respiratory | 0.366 |
| NR-Aromatase | 0.027 |
| Antiviral | No |
| Prediction | 0.696939 |